🇺🇸 FDA
Patent

US 11439615

Lipoxin and lipoxin analogue mediated neuroprotection and treatments

granted A61KA61K31/202A61K31/557

Quick answer

US patent 11439615 (Lipoxin and lipoxin analogue mediated neuroprotection and treatments) held by The Regents of the University of California expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/202, A61K31/557, A61P, A61P25/00